Pesquisar neste blogue

31 julho 2020

ONE factor explains most of the differences in Covid19 deaths across countries

ONE factor explains most of the differences in Covid19 deaths across countries: Countries with a lot of old men will simply suffer a lot bigger blow than countries with younger populations.

Covid19 deaths POP

COVID-19 Guidance and Resources

COVID-19 Guidance and Resources: a collection of privacy news, resources, guidance and tools covering the COVID-19 global outbreak.

Comparisons of all-cause mortality between European countries

Comparisons of all-cause mortality between European countries and regions

‘Coronationalism’ vs a geopolitical Europe?

‘Coronationalism’ vs a geopolitical Europe? EU member states have been discussing how to deal with the socio-economic repercussions of the Covid-19 pandemic, collectively. While lively debates about internal solidarity continue, there is also the pressing issue of how the EU and its member states wish to support third countries, outside the EU, in tackling their health and economic emergencies.

On the one hand, the EU wishes to become a geopolitical power, which demands that the Union and its member states step up their supportive role on the global scene. On the other, there are signs of ‘coronationalism,’ with some national political parties questioning the timing of EU external aid when member states themselves are struggling.

Based on expert contributions from a representative cross-section of 13 member states, this paper delves into the question of whether and how external solidarity features in political and public discourse in Covid-struck Europe. It finds that, for now, neither coronationalist nor geopolitical ambitions dominate the relatively little politicised debates about international cooperation and development aid.

AstraZeneca to be exempt from coronavirus-vaccine liability claims in most countries

AstraZeneca to be exempt from coronavirus-vaccine liability claims in most countries: AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements, a senior executive told Reuters.

With 25 companies testing their vaccine candidates on humans and getting ready to immunise hundred millions of people once the products are shown to work, the question of who pays for any claims for damages in case of side effects has been a tricky point in supply negotiations.

“This is a unique situation where we as a company simply cannot take the risk if in ... four years the vaccine is showing side effects,” Ruud Dobber, a member of Astra’s senior executive team, told Reuters.

“In the contracts we have in place, we are asking for indemnification. For most countries it is acceptable to take that risk on their shoulders because it is in their national interest,” he said, adding that Astra and regulators were making safety and tolerability a top priority.

Dobber would not name the countries.

EU officials told Reuters this week product liability was among contentious points in European efforts to secure supply deals for potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson.

Compulsory licensing and access to future Covid-19 vaccines

Compulsory licensing and access to future Covid-19 vaccines: This paper examines compulsory licensing and Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health as policy alternatives to voluntary licensing for access to affordable future Covid-19 vaccines. With regard to manufacturing capacity, the EU and its member states may not be eligible to import since they opted out of the Paragraph 6 system outright (although they may still export under the same system). Fortunately, this does not appear to be a major problem since statistics show that most EU27 imports of all pharmaceuticals are from Europe itself, with China a distant second supplier.

Exploiting isolation: sexual predators increasingly targeting children during COVID pandemic

Exploiting isolation: sexual predators increasingly targeting children during COVID pandemic | Europol: A further increase in sharing of child abuse material online, sexual coercion and extortion of children is expected

30 julho 2020

How Will a Coronavirus Vaccine Work?

How Will a Coronavirus Vaccine Work? Four different ways researchers use the virus’s own structure to train our immune systems to exterminate it.

OMS: Hydroxychloroquine and COVID-19

Q&A : Hydroxychloroquine and COVID-19: hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.

Coronavirus and hydroxychloroquine: What do we know?

Coronavirus and hydroxychloroquine: What do we know? But despite some early studies raising hopes, one subsequent larger scale trial has shown it's not effective as a treatment.

The World Health Organization (WHO) has halted its trials, saying that the drug doesn't reduce death rates in patients with coronavirus.

How Covid-19 Could Give Kim Jong Un a Doomsday Weapon

How Covid-19 Could Give Kim Jong Un a Doomsday Weapon: North Korea’s secrecy makes it hard to know anything definitive about the state of its bioweapons program.

The Race for a Coronavirus Vaccine

The Race for a Coronavirus Vaccine: Latest Update & Developments: Rarely has the fate of the world depended on an international competition like the one for a Covid-19 vaccine. It's a race against time, it's a race to save lives, it's a race for glory. Trials are underway.

How Long Does Coronavirus Last in the Body?

How Long Does Coronavirus Last in the Body? “There are probably all sorts of stages in the middle between the acute
infection and the persistent infection, and it’s not just an academic
armchair pursuit. It may actually make a difference in terms of
understanding disease.”

Strengthening Privacy Protections in COVID-19 Mobile Phone–Enhanced Surveillance Programs

Strengthening Privacy Protections in COVID-19 Mobile Phone–Enhanced Surveillance Programs: Facilitated by a trove of technology-based data sources—in particular, the data generated from the widespread use of mobile phones—these public health surveillance programs could prove especially valuable for preventing successive waves of infections as quarantine orders are relaxed and economies reopen.

How the world made so much progress on a Covid-19 vaccine so fast

How the world made so much progress on a Covid-19 vaccine so fast

Virologists divided over plans to change virus-naming rules

Virologists divided over plans to change virus-naming rules during the pandemic: Researchers say now is bad time to introduce a system for naming viral
species, when scientists are focused on the coronavirus outbreak.

Why a worldwide Marshall Plan can create healthier cities

Why a worldwide Marshall Plan can create healthier cities

How Covid-19 is Transforming the News

A New Era of Journalism: How Covid-19 is Transforming the News: accelerating the speed of journalistic innovation

A Coronavirus Vaccine Could Hinge on This Experiment

A Coronavirus Vaccine Could Hinge on This Experiment: Inside the movement to launch a human challenge trial for Covid-19

Ethical considerations to guide the use of digital proximity tracking technologies for COVID-19 contact tracing

Ethical considerations to guide the use of digital proximity tracking technologies for COVID-19 contact tracing: Digital proximity tracking technologies have been identified as a potential tool to support contact tracing for COVID-19. However, these technologies raise ethical and privacy concerns.

Pandemic Planning Scenarios

COVID-19 Pandemic Planning Scenarios | CDC: CDC and the Office of the Assistant Secretary for Preparedness and Response (ASPR) have developed five COVID-19 Pandemic Planning Scenarios that are designed to help inform decisions by public health officials who use mathematical modeling and by mathematical modelers throughout the federal government.

Europe’s Other Coronavirus Victim: Information and Data Rights

Europe’s Other Coronavirus Victim: Information and Data Rights: Arbitrary arrests, surveillance, phone tapping and privacy breaches increase as countries of Central and Southeast Europe impose emergency laws to combat Covid-19

Vaccines may arrive in record time, but the virus has been faster

Vaccines may arrive in record time, but the virus has been faster: Baden and others involved in developing and testing other vaccine candidates said getting one approved for wide use is unlikely before early next year.

29 julho 2020

Understanding medical uncertainty in the hydroxychloroquine debate

Understanding medical uncertainty in the hydroxychloroquine debate: The debate over hydroxychloroquine has become deeply politicized, which has obscured more nuanced debates within the scientific community over what constitutes actionable evidence.

Working from Home During COVID

Working from Home During COVID: New cautions for HR managers on worker surveillance

Walls Are Back

Walls Are Back: In its 2019 workplace survey, Gensler found that 65 percent of respondents wanted at least semiprivate workspaces; another quarter wanted on-demand access to private spaces. At home, the American Institute of Architects’ annual survey of residential architects found double-digit declines in interest in open layouts compared with the previous year in both 2019 and 2020.

Taller people are at higher risk of coronavirus

People over 6ft have double the risk of coronavirus, study suggests: The team found taller people are at higher risk, which scientists say
suggests coronavirus is transmitting through the air because height
would not make a difference if people were contracting it exclusively
through droplets. 

Vaccine nationalism threatens global plan to distribute COVID-19 shots fairly

‘Vaccine nationalism’ threatens global plan to distribute COVID-19 shots fairly: As soon as the first COVID-19 vaccines get approved, a staggering global need will confront limited supplies. Many health experts say it’s clear who should get the first shots: health care workers around the world, then people at a higher risk of severe disease, then those in areas where the disease is spreading rapidly, and finally, the rest of us. Such a strategy “saves the most lives and slows transmission the fastest,” says Christopher Elias, who heads the Bill & Melinda Gates Foundation’s Global Development Division. “It would be ludicrous if low-risk people in rich countries get the vaccine when health care workers in South Africa don’t,” adds Ellen ‘t Hoen, a Dutch lawyer and public health activist.

What readers want to know about coronavirus

Asked and answered: What readers want to know about coronavirus: Asked and answered: What readers want to know about coronavirus

The scale of coronavirus deaths

The scale of coronavirus deaths: global pandemic has claimed the lives of over 650,000 people globally.